# TScan Therapeutics, Inc.: Form DEF 14A, filed Apr 17, 2026

- Company: [TScan Therapeutics, Inc.](/companies/tcrx.md) (CIK 1783328)
- Form: DEF 14A
- Filed: 2026-04-17
- Accepted by EDGAR: Apr 17, 2026, 07:30 ET
- Period: 2026-05-20
- Accession: 0001193125-26-160304
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1783328/000119312526160304/d26976ddef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1783328/000119312526160304/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1783328/000119312526160304/d26976ddef14a.htm

Filed Apr 17, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-160304. Last ingested by Listed: Nov 12, 2026, 17:50 ET. No prices; not investment advice.
